Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang-In Lin

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 28, 2025
Targeting serine metabolism vulnerability in omipalisib-resistant acute myeloid leukemia with phosphoglycerate dehydrogenase inhibitorsChi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou, et al.
Acta Histochemica|November 28, 2015
Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic markerYi-Jung Ho, Yueh-Min Lin, Yen-Chi Huang, et al.
Cancer Gene Therapy|October 11, 2023
Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesisChi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou, et al.
Journal of Clinical Microbiology|November 1, 2002
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapySung-Hsin Kuo, Liang-In Lin, Chee-Jen Chang, et al.
Biomed Research International|June 12, 2015
Zebrafish as a Model for the Study of Human Myeloid MalignanciesJeng-Wei Lu, Meng-Shan Hsieh, Heng-An Liao, et al.
Life Sciences|April 26, 2006
Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cellsUe-Min Chang, Chyi-Hann Li, Liang-In Lin, et al.
Haematologica|March 4, 2017
Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implicationsShang-Ju Wu, Chien-Ting Lin, Andreas Agathangelidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionChiun Hsu, Liang-In Lin, Yu-Che Cheng, et al.
Cancers|January 21, 2022
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in CancerChing-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, et al.
Plos One|July 3, 2013
Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwayDa-Liang Ou, Bin-Shyun Lee, Ya-Chi Chang, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 28, 2025
Targeting serine metabolism vulnerability in omipalisib-resistant acute myeloid leukemia with phosphoglycerate dehydrogenase inhibitorsChi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou, et al.
Acta Histochemica|November 28, 2015
Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic markerYi-Jung Ho, Yueh-Min Lin, Yen-Chi Huang, et al.
Cancer Gene Therapy|October 11, 2023
Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesisChi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou, et al.
Journal of Clinical Microbiology|November 1, 2002
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapySung-Hsin Kuo, Liang-In Lin, Chee-Jen Chang, et al.
Biomed Research International|June 12, 2015
Zebrafish as a Model for the Study of Human Myeloid MalignanciesJeng-Wei Lu, Meng-Shan Hsieh, Heng-An Liao, et al.
Life Sciences|April 26, 2006
Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cellsUe-Min Chang, Chyi-Hann Li, Liang-In Lin, et al.
Haematologica|March 4, 2017
Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implicationsShang-Ju Wu, Chien-Ting Lin, Andreas Agathangelidis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionChiun Hsu, Liang-In Lin, Yu-Che Cheng, et al.
Cancers|January 21, 2022
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in CancerChing-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, et al.
Plos One|July 3, 2013
Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwayDa-Liang Ou, Bin-Shyun Lee, Ya-Chi Chang, et al.
Pageof 9